Clearbridge Health (1H3.SI, SES) up 100% intraday 09 Apr 2026: low liquidity drives the move

The 1H3.SI stock leapt 100.00% intraday to S$0.002 on 09 Apr 2026, driven by tiny trading volume of 200 shares versus an average of 5,942,930. This spike is a liquidity-driven move on the SES (Singapore) rather than a clear change in fundamentals. Traders should note the wide gap between the current price and the Meyka AI yearly forecast, and treat the intraday gain as a volatility event tied to micro-cap dynamics.

Intraday price action and liquidity for 1H3.SI stock

Clearbridge Health Limited (1H3.SI) traded between S$0.002 and S$0.002 today on the SES. Volume was 200 shares compared with an average volume of 5,942,930, showing extreme illiquidity. A 100.00% one-day move on such low turnover indicates the rise was caused by a small number of trades against a thin order book rather than broad buying interest.

Valuation and financial snapshot for 1H3.SI stock

At S$0.002, Clearbridge Health’s market cap is about S$8,591,642 with 4,295,820,825 shares outstanding. Key ratios: P/S 0.87, P/B 1.91, Debt/Equity 0.42, current ratio 1.51. The company reports negative earnings per share and a trailing PE shown as negative, reflecting losses. These metrics show a low market valuation but negative profitability, typical of a small healthcare services holding.

Technicals and trading signals on 1H3.SI stock

Technical indicators are mixed. RSI sits at 53.26, suggesting neutral momentum. ADX at 31.72 signals a strong trend, but zeroed MACD and near-zero ATR reflect limited price history and flat intraday ranges. With Year High S$0.005 and Year Low S$0.001, the stock is volatile in percentage terms. Given the tiny float and avg volume gap, standard technical signals can mislead short-term traders.

Meyka AI grade and analyst consensus for 1H3.SI stock

Meyka AI rates 1H3.SI with a score out of 100: 58.57 | Grade: C+ | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Note external company-level rating dated 08 Apr 2026 shows C- / Strong Sell on fundamental DCF and profitability metrics, underscoring mixed signals between model grades and other rating systems.

Risks, catalysts and upcoming events for 1H3.SI stock

Primary risks are very low liquidity, negative EPS, and limited free cash flow. Catalysts include the scheduled earnings announcement on 19 Aug 2026, potential strategic investments, and any regional clinic contract wins. With receivables days at 113.63 and operating margins negative, operational improvements or a capital raise would materially affect valuation and share supply.

Price targets and Meyka AI forecast for 1H3.SI stock

Meyka AI’s forecast model projects a yearly price of S$0.00512, a three-year price of S$0.01168, and a five-year price of S$0.01822. Based on today’s S$0.002, the model implies a yearly upside of 156.22% to S$0.00512. For risk-aware traders we set conservative near-term target S$0.003, base case S$0.005, and optimistic S$0.012 over three years. Forecasts are model-based projections and not guarantees.

Final Thoughts

Clearbridge Health (1H3.SI) is a micro-cap healthcare name that produced a 100.00% intraday move on 09 Apr 2026 largely because of extreme illiquidity. The stock trades at S$0.002 with a market cap near S$8.59M, negative EPS, and modest book value per share, which explains mixed ratings across models. Meyka AI’s forecast model projects S$0.00512 in one year, implying ~156.22% upside from the current price, but this projection is model-driven and not a guarantee. Short-term traders should expect high volatility and wide spreads. Long-term investors need clear operational improvements, better cash flow and higher trading liquidity before considering a BUY. For more real-time updates use Meyka AI’s AI-powered market analysis platform and reference company filings on the Clearbridge website and official exchange disclosures Clearbridge Health website and Financial Modeling Prep company data.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.